title: Dual infection with Mycobacterium tuberculosis and Pneumocystis jiroveci Lymphadenitis in a Patient with HIV infection: case report and review of the literature.
abstract: We report a case of dual Mycobacterium tuberculosis (TB) and Pneumocystis jiroveci (carinii) (PCP) lymphadenitis in a patient with HIV who had been receiving trimethoprim-sulfamethoxazole (TMP-SMX) as systemic prophylaxis for PCP. This patient was successfully treated with antituberculosis medications and TMP-SMX. Our review of the literature identified this as the first reported case of dual TB and PCP lymphadenitis in an HIV-infected host and highlights the potential limitations of TMP-SMX prophylaxis.
authors.affiliation: Department of Medicine, Thammasart University Hospital, Pratumthani, Thailand.
authors.forename: Thana
authors.initials: T
authors.lastname: Khawcharoenporn
authors.forename: Anucha
authors.initials: A
authors.lastname: Apisarnthanarak
authors.forename: Dussadee
authors.initials: D
authors.lastname: Sakonlaya
authors.forename: Linda M
authors.initials: LM
authors.lastname: Mundy
authors.forename: Thomas C
authors.initials: TC
authors.lastname: Bailey
mesh_terms: D000328:Adult; D019072:Antibiotic Prophylaxis; D005260:Female; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D008199:Lymphadenitis / Q000150:complications* / Q000382:microbiology; D009169:Mycobacterium tuberculosis; D016720:Pneumocystis Infections / Q000150:complications* / Q000382:microbiology; D045363:Pneumocystis carinii; D011020:Pneumonia, Pneumocystis / Q000517:prevention & control; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D014388:Tuberculosis, Lymph Node / Q000150:complications* / Q000382:microbiology
chemical_list: D015662:Trimethoprim, Sulfamethoxazole Drug Combination